{
  "title": "Newsletter",
  "intro": "```json\n{\n  \"title\": \"LAI Intelligence Weekly â€“ December 8, 2025\",\n  \"intro\": \"This week's intelligence highlights competitive dynamics in hemophilia therapeutics, regulatory developments across key markets, and strategic marketing investments in immunology. Notable activity includes Pfizer's ASH data presentation, FDA safety investigations, and unprecedented pharma sponsorship of public health awareness initiatives. The period reflects continued focus on specialty care franchises and geographic",
  "tldr": [],
  "sections": []
}